Back to HomeBeta

ICD-10 Coding for Bradykinin-Related Conditions(U07.1, D84.1)

Complete ICD-10-CM coding and documentation guide for Bradykinin-Related Conditions. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Bradykinin ViremiaBradykinin Dysregulation

Related ICD-10 Code Ranges

Complete code families applicable to Bradykinin-Related Conditions

U07.1Primary Range

COVID-19, virus identified

Primary code for COVID-19-related bradykinin dysregulation.

Hereditary angioedema

Used for hereditary angioedema with bradykinin-mediated angioedema.

Other abnormal findings in blood

Used to document elevated bradykinin levels as a lab finding.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
U07.1COVID-19, virus identifiedUse when COVID-19 is confirmed and associated with bradykinin dysregulation.
  • Confirmed SARS-CoV-2 infection
  • Elevated des-Arg9-bradykinin levels
D84.1Hereditary angioedemaUse for hereditary angioedema with confirmed bradykinin elevation.
  • Cold-induced bradykinin elevation confirmed via LC-MS/MS

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for bradykinin viremia

Essential facts and insights about Bradykinin-Related Conditions

Bradykinin viremia is not directly coded in ICD-10. Use U07.1 for COVID-19 with bradykinin dysregulation.

Primary ICD-10-CM Codes for bradykinin viremia

COVID-19, virus identified
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed COVID-19 with elevated bradykinin levels

Applicable To

  • SARS-CoV-2 infection

Excludes

  • B97.29 (Other coronavirus as the cause of diseases classified elsewhere)

Clinical Validation Requirements

  • Confirmed SARS-CoV-2 infection
  • Elevated des-Arg9-bradykinin levels

Code-Specific Risks

  • Misclassification with other coronavirus codes

Coding Notes

  • Ensure COVID-19 is sequenced first when it is the underlying cause.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other abnormal findings in blood

R89.89
Document elevated bradykinin levels.

Localized edema

R60.0
Document angioedema.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Other coronavirus as the cause of diseases classified elsewhere

B97.29
Use only for non-SARS-CoV-2 coronaviruses.

Angioedema due to histamine

T78.3XXA
Presence of urticaria and response to antihistamines.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Bradykinin-Related Conditions to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code U07.1.

Impact

Clinical: Misinterpretation of clinical severity., Regulatory: Non-compliance with documentation standards., Financial: Potential denial of claims due to insufficient documentation.

Mitigation Strategy

Use specific language in documentation, Include quantitative data

Impact

Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data reporting for COVID-19 cases.

Mitigation Strategy

Always use U07.1 for confirmed COVID-19 cases.

Impact

Incorrect sequencing of COVID-19 codes.

Mitigation Strategy

Ensure U07.1 is sequenced first when COVID-19 is the primary condition.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Bradykinin-Related Conditions, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Bradykinin-Related Conditions

Use these documentation templates to ensure complete and accurate documentation for Bradykinin-Related Conditions. These templates include all required elements for proper coding and billing.

COVID-19 with hepatic injury

Specialty: Infectious Disease

Required Elements

  • Confirmed SARS-CoV-2 infection
  • Elevated transaminases
  • Plasma des-Arg9-bradykinin levels

Example Documentation

Patient with confirmed SARS-CoV-2 infection (U07.1) presents with elevated transaminases (ALT 150 U/L) and plasma des-Arg9-bradykinin 786 pg/mL (LC-MS/MS).

Examples: Poor vs. Good Documentation

Poor Documentation Example
High inflammatory markers in COVID-19.
Good Documentation Example
Elevated plasma des-Arg9-bradykinin (786.3 pg/mL via LC-MS/MS) with hepatic congestion in confirmed SARS-CoV-2 infection.
Explanation
The good example specifies the exact marker and method of measurement, providing clear clinical evidence.

Need help with ICD-10 coding for Bradykinin-Related Conditions? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more